ANIP Financials
Ani Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$78.29
Market Cap
$1.78B
P/E Ratio
23.6
EPS
$3.32
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$614.38M
Gross Profit
-
Operating Income
-
Net Income
$-18.52M
EPS (Diluted)
$-1.04
Balance Sheet Highlights
Total Assets
$1.28B
Total Liabilities
$855.17M
Shareholders Equity
-
Cash & Equivalents
$144.86M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$64.02M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
61.4%
Operating Margin
0.1%
Net Margin
0.1%
ROE
0.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ANIP revenue?
ANIP's most recent quarterly revenue was $614.38M. Annual revenue can be calculated by summing the four most recent quarters.
Is ANIP profitable?
ANIP reported a loss of $18.52M in the most recent quarter. The net profit margin is 0.1%.
What is ANIP market cap?
ANIP has a market capitalization of $1.78B, making it a small-cap stock.
Does ANIP have debt?
View ANIP's balance sheet for debt information.
What is ANIP cash flow?
Cash flow data is available in the full financial statements.